News

Academic partner Oslo University Hospital presented clinical data on compassionate use of AML DC vaccine at ASH

SHOW RELEASE

Medigene participates at further upcoming conferences

SHOW RELEASE

Medigene reports financial & business results for the first nine months of 2018

SHOW RELEASE

Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor

SHOW RELEASE

Medigene participates at four conferences in November

SHOW RELEASE

Medigene participates at four conferences in October

SHOW RELEASE

Medigene participates at further conferences in September

SHOW RELEASE

Medigene announces inclusion in SDAX

SHOW RELEASE

Medigene announces change in executive leadership team

SHOW RELEASE

Medigene and Structured Immunity announce collaboration aimed at improving T Cell receptor development

SHOW RELEASE

Medigene Reports Results for the First Half of 2018

SHOW RELEASE

Medigene presents at upcoming conferences

SHOW RELEASE

Medigene CEO Dolores Schendel Receives Bavarian Order of Merit

SHOW RELEASE

Medigene presents at five upcoming conferences

SHOW RELEASE

Medigene successfully raises EUR 32.3 million in oversubscribed private placement

SHOW RELEASE